IFNG and neoplasm: Third-generation CAR-T cells have two additional costimulatory molecules, i.e., 4-1BB and CD28, which helped them produce a significant amount of toxic cytokines (IFN-γ) compared to first-generation or second-generation CAR-T cells that enhance the lysis of tumor cells.